119 related articles for article (PubMed ID: 17912028)
1. Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer.
Jain M; Kumar S; Upadhyay R; Lal P; Tiwari A; Ghoshal UC; Mittal B
Cancer Biol Ther; 2007 Oct; 6(10):1553-8. PubMed ID: 17912028
[TBL] [Abstract][Full Text] [Related]
2. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
[TBL] [Abstract][Full Text] [Related]
3. Interaction of EGFR 497Arg>Lys with EGF +61A>G polymorphism: modulation of risk in esophageal cancer.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Oncol Res; 2008; 17(4):167-74. PubMed ID: 18773861
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab.
Zhang W; Gordon M; Press OA; Rhodes K; Vallböhmer D; Yang DY; Park D; Fazzone W; Schultheis A; Sherrod AE; Iqbal S; Groshen S; Lenz HJ
Pharmacogenet Genomics; 2006 Jul; 16(7):475-83. PubMed ID: 16788380
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer.
Dahan L; Norguet E; Etienne-Grimaldi MC; Formento JL; Gasmi M; Nanni I; Gaudart J; Garcia S; Ouafik L; Seitz JF; Milano G
BMC Cancer; 2011 Nov; 11():496. PubMed ID: 22117530
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
Sun T; Miao X; Zhang X; Tan W; Xiong P; Lin D
J Natl Cancer Inst; 2004 Jul; 96(13):1030-6. PubMed ID: 15240787
[TBL] [Abstract][Full Text] [Related]
7. [The association between polymorphism of transforming growth factor-β1 and radiochemotherapy response and survival in esophageal squamous cell carcinoma patients].
Zhou YL; Zhang WC; Chen XB; Xiao ZF; Qiao Y; Yu DK; Lin DX; Tan W
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jul; 45(7):583-7. PubMed ID: 22041558
[TBL] [Abstract][Full Text] [Related]
8. Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population?
Mandal RK; Mittal RD
Urol Oncol; 2012 Sep; 30(5):555-61. PubMed ID: 20822933
[TBL] [Abstract][Full Text] [Related]
9. ATM, BCL2, and TGFβ Gene Polymorphisms as Radiotherapy Outcome Biomarkers in Head and Neck Squamous Cell Carcinoma Patients.
Agostini LP; Stur E; Garcia FM; Ventorim DP; Dos Reis RS; Dettogni RS; Dos Santos EVW; Peterle GT; Maia LL; Mendes SO; de Carvalho MB; Tajara EH; de Paula F; Dos Santos M; da Silva AMA; Louro ID
Genet Test Mol Biomarkers; 2017 Dec; 21(12):727-735. PubMed ID: 29135311
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of common genetic variants in pre-microRNA in susceptibility and prognosis of esophageal cancer.
Umar M; Upadhyay R; Prakash G; Kumar S; Ghoshal UC; Mittal B
Mol Carcinog; 2013 Nov; 52 Suppl 1():E10-8. PubMed ID: 22692992
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of CCND1 and PTEN in progression of esophageal squamous carcinoma.
Jang Y; Lu SA; Chen ZP; Ma J; Xu CQ; Zhang CZ; Wang JJ
Genet Mol Res; 2013 Dec; 12(4):6685-91. PubMed ID: 24391010
[TBL] [Abstract][Full Text] [Related]
12. Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area.
Hussain S; M Y; Thakur N; Salam I; Singh N; Mir MM; Bhat MA; Siddiqi MA; Das BC; Bharadwaj M
Mol Carcinog; 2011 Jul; 50(7):487-98. PubMed ID: 21268129
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma.
Sunpaweravong P; Sunpaweravong S; Puttawibul P; Mitarnun W; Zeng C; Barón AE; Franklin W; Said S; Varella-Garcia M
J Cancer Res Clin Oncol; 2005 Feb; 131(2):111-9. PubMed ID: 15672286
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population.
Fernández-Mateos J; Seijas-Tamayo R; Mesía R; Taberna M; Pastor Borgoñón M; Pérez-Ruiz E; Adansa Klain JC; Vázquez Fernández S; Del Barco Morillo E; Lozano A; González Sarmiento R; Cruz-Hernández JJ;
Oral Oncol; 2016 Dec; 63():38-43. PubMed ID: 27938998
[TBL] [Abstract][Full Text] [Related]
15. The effect of CCND1 +870A>G and VEGF +936C>T polymorphisms on oral cancer development and disease-free survival in a Taiwan population.
Lin YC; Yeh CJ; Wang LH; Lee CW; Chen CH
Oral Oncol; 2012 Jun; 48(6):535-40. PubMed ID: 22321253
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
[TBL] [Abstract][Full Text] [Related]
17. Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3.
Friess H; Fukuda A; Tang WH; Eichenberger A; Furlan N; Zimmermann A; Korc M; Büchler MW
World J Surg; 1999 Oct; 23(10):1010-8. PubMed ID: 10512940
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 G870A polymorphism and squamous cell carcinoma of the uterine cervix in Korean women.
Jeon YT; Kim JW; Song JH; Park NH; Song YS; Kang SB; Lee HP
Cancer Lett; 2005 Jun; 223(2):259-63. PubMed ID: 15896460
[TBL] [Abstract][Full Text] [Related]
19. Genetic Variants in EGFR/PLCE1 Pathway Are Associated with Prognosis of Esophageal Squamous Cell Carcinoma after Radical Resection.
Wang YL; Yuan Y; Luo XX; Hu GY; Gong P
Curr Med Sci; 2019 Jun; 39(3):385-390. PubMed ID: 31209807
[TBL] [Abstract][Full Text] [Related]
20. The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma.
Jia J; Cui Y; Lu M; Wang X; Li J; Li J; Li Y; Zhang X; Gao J; Zhou J; Lu Z; Gong J; Yu J; Sun Z; Liu C; Shen L; Zhang X
Clin Transl Oncol; 2016 Jun; 18(6):592-8. PubMed ID: 26459251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]